BioMed is a peer-reviewed english-language open-access journal published by MDPI AG in Switzerland, operating under an open-access model since 2021. The journal covers Chemical technology: Biotechnology and Medicine.
Authors are required to pay an article processing charge to publish in BioMed; refer to the journal's APC page for the current rate. A waiver policy is offered for eligible authors. Articles are released under the CC BY, Publisher's own license license (see other journals using this license).
To date, BioMed has published 169 articles. Articles are minted with DOIs through the prefix 10.3390. All submissions undergo plagiarism screening before peer review.
Keywords
clinical medicine, basic medical science, public health, biomedical engineering, biotechnology, cardiology and cardiovascular medicine
At a glance
- Publisher
- MDPI AG
- Country
- Switzerland
- Primary language
- English
- License
- CC BY, Publisher's own license
- Peer review
- Anonymous peer review
- OA since
- 2021
- Review time
- 6 weeks
- DOI prefix
10.3390- Plagiarism check
- Yes
ISSN
- electronic
- 2673-8430
Frequently asked questions
Is BioMed peer-reviewed?
Does BioMed charge an article processing charge (APC)?
What subjects does BioMed publish?
What languages does BioMed accept?
What is the ISSN of BioMed?
2673-8430 (electronic).